<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01706445</url>
  </required_header>
  <id_info>
    <org_study_id>kid'strainingCF</org_study_id>
    <secondary_id>CFtraining</secondary_id>
    <nct_id>NCT01706445</nct_id>
  </id_info>
  <brief_title>Combined Inspiratory Muscle and 'Whole Muscle' Training in Children With Cystic Fibrosis</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidad Europea de Madrid</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Hospital Infantil Universitario Niño Jesús, Madrid, Spain</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Universidad Europea de Madrid</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To study the effects of an 8-week combined inspiratory muscle training and exercise
      (resistance+aerobic) program on of a lung volume, inspiratory muscle strength (maximal
      inspiratory pressure, PImax) and cardiorespiratory fitness (maximal oxygen uptake, VO2peak)
      (primary outcomes)and dynamic muscle strength, body composition and quality of life (QoL) in
      children with Cystic Fibrosis (CF) (secondary outcomes).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators hypothesized that the combined training program would significantly benefit
      most of the aforementioned variables (especially, primary outcomes).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2011</start_date>
  <primary_completion_date type="Actual">July 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>cardiorespiratory fitness (VO2peak)</measure>
    <time_frame>this outcome will be assessed up to 12 weeks</time_frame>
    <description>maximum oxygen uptake (VO2peak), which is the best indicator of aerobic fitness in humans and an independent mortality predictor in children with cystic fibrosis</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>quality of life</measure>
    <time_frame>this outcome will be assessed up to 12 weeks</time_frame>
    <description>children's QoL with the Spanish Version (1.0) of the Cystic Fibrosis Questionnaire-Revised (CFQ-R).</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Maximal inspiratory pressure (PImax)</measure>
    <time_frame>september 2011-july 2012</time_frame>
    <description>an indicator of the strength of inspiratory muscles</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Cystic Fibrosis</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>intervention</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Exercise training</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Other</intervention_name>
    <description>inspiratory muscle training (IMT) + aerobic and strength training 8-week duration IMT twice a day (mostly at home) + 3 weekly sessions of inhospital resistance + aerobic training</description>
    <arm_group_label>intervention</arm_group_label>
    <other_name>Exercise training</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  boy/girl aged 6-17 years

          -  living in the Madrid area

        Exclusion Criteria:

          -  severe lung deterioration [forced expiratory volume (FEV1) &lt;50% of expected]

          -  unstable clinical condition (hospitalization within the previous 3 months)

          -  Burkholderia cepacia infection

          -  any disorder (e.g. muscle-skeletal) impairing exercise.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hospital Infantil Universitario Niño Jesús</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>October 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 9, 2012</study_first_submitted>
  <study_first_submitted_qc>October 11, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 15, 2012</study_first_posted>
  <last_update_submitted>October 11, 2012</last_update_submitted>
  <last_update_submitted_qc>October 11, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 15, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universidad Europea de Madrid</investigator_affiliation>
    <investigator_full_name>Alejandro Lucia</investigator_full_name>
    <investigator_title>MD PhD</investigator_title>
  </responsible_party>
  <keyword>cystic fibrosis</keyword>
  <keyword>exercise</keyword>
  <keyword>children</keyword>
  <keyword>cardiorespiratory fitness</keyword>
  <keyword>muscle strength</keyword>
  <keyword>pulmonary function</keyword>
  <keyword>quality of life</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fibrosis</mesh_term>
    <mesh_term>Cystic Fibrosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

